161 related articles for article (PubMed ID: 24835851)
1. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
2. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
[TBL] [Abstract][Full Text] [Related]
3. Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling.
Peng H; Ye T; Deng L; Yang X; Li Q; Tong J; Guo J
Gut Liver; 2024 May; 18(3):476-488. PubMed ID: 37458065
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells.
Czerwinski MJ; Desiderio V; Shkeir O; Papagerakis P; Lapadatescu MC; Owen JH; Athanassiou-Papaefthymiou M; Zheng L; Papaccio G; Prince ME; Papagerakis S
Otolaryngol Head Neck Surg; 2013 Jul; 149(1):97-104. PubMed ID: 23558285
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated ALDH m
Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
Wu X; Cheng YL; Matthen M; Yoon A; Schwartz GK; Bala S; Taylor AM; Momen-Heravi F
J Exp Clin Cancer Res; 2021 Feb; 40(1):70. PubMed ID: 33596979
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas.
Huang C; Yoon C; Zhou XH; Zhou YC; Zhou WW; Liu H; Yang X; Lu J; Lee SY; Huang K
Cell Death Dis; 2020 Apr; 11(4):266. PubMed ID: 32327629
[TBL] [Abstract][Full Text] [Related]
8. Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Nakashoji A; Haratake N; Bhattacharya A; Mao W; Xu K; Wang K; Daimon T; Ozawa H; Shigeta K; Fushimi A; Yamashita N; Morimoto Y; Shimokawa M; Saito S; Egloff AM; Uppaluri R; Long MD; Kufe D
Cancer Res Commun; 2024 May; 4(5):1268-1281. PubMed ID: 38619287
[TBL] [Abstract][Full Text] [Related]
9. Melatonin inhibits the stemness of head and neck squamous cell carcinoma by modulating HA synthesis via the FOSL1/HAS3 axis.
Luo X; Wang J; Chen Y; Zhou X; Shao Z; Liu K; Shang Z
J Pineal Res; 2024 Mar; 76(2):e12940. PubMed ID: 38402581
[TBL] [Abstract][Full Text] [Related]
10. Head and neck cancer stem cells.
Krishnamurthy S; Nör JE
J Dent Res; 2012 Apr; 91(4):334-40. PubMed ID: 21933937
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.
Sahara S; Warner KA; Herzog AE; Zhang Z; Nör JE
Oral Oncol; 2023 Jul; 142():106437. PubMed ID: 37267716
[TBL] [Abstract][Full Text] [Related]
12. Modeling head and neck cancer stem cell-mediated tumorigenesis.
Pearson AT; Jackson TL; Nör JE
Cell Mol Life Sci; 2016 Sep; 73(17):3279-89. PubMed ID: 27151511
[TBL] [Abstract][Full Text] [Related]
13. The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma.
Shah A; Patel S; Pathak J; Swain N; Kumar S
ScientificWorldJournal; 2014; 2014():842491. PubMed ID: 24574924
[TBL] [Abstract][Full Text] [Related]
14. Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels.
Kim HS; Chen YC; Nör F; Warner KA; Andrews A; Wagner VP; Zhang Z; Zhang Z; Martins MD; Pearson AT; Yoon E; Nör JE
Oncotarget; 2017 Nov; 8(59):100339-100352. PubMed ID: 29245982
[TBL] [Abstract][Full Text] [Related]
15. Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.
Affolter A; Lammert A; Kern J; Scherl C; Rotter N
Front Cell Dev Biol; 2021; 9():666515. PubMed ID: 34307351
[TBL] [Abstract][Full Text] [Related]
16. β-Tubulin Isotype, TUBB4B, Regulates The Maintenance of Cancer Stem Cells.
Dharmapal D; Jyothy A; Mohan A; Balagopal PG; George NA; Sebastian P; Maliekal TT; Sengupta S
Front Oncol; 2021; 11():788024. PubMed ID: 35004310
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development.
Deng L; Shang L; Bai S; Chen J; He X; Martin-Trevino R; Chen S; Li XY; Meng X; Yu B; Wang X; Liu Y; McDermott SP; Ariazi AE; Ginestier C; Ibarra I; Ke J; Luther T; Clouthier SG; Xu L; Shan G; Song E; Yao H; Hannon GJ; Weiss SJ; Wicha MS; Liu S
Cancer Res; 2014 Nov; 74(22):6648-60. PubMed ID: 25217527
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Tumor Resection and Radiotherapy on the Expression of Stem Cell Markers (CD44 and CD133) in Patients with Squamous Cell Carcinoma.
Paya L; Rafat A; Talebi M; Aghbali A; Shahidi N; Nejati B; Emamverdizadeh P; Nozad Charoudeh H
Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):92-99. PubMed ID: 38680713
[No Abstract] [Full Text] [Related]
19. Significance of ATP-binding cassette transporter proteins in multidrug resistance of head and neck squamous cell carcinoma.
Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
Oncol Lett; 2015 Aug; 10(2):631-636. PubMed ID: 26622545
[TBL] [Abstract][Full Text] [Related]
20. The biomarkers for maintenance Cancer stem cell features can be applicable in precision medicine of head and neck squamous cell carcinoma.
Shayan N; Ghiyasimoghaddam N; Mirkatuli HA; Baghbani M; Ranjbarzadhagh Z; Mohtasham N
J Stomatol Oral Maxillofac Surg; 2024 Apr; ():101906. PubMed ID: 38688401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]